` SCU (Stemcell United Ltd) vs S&P/ASX 300 Comparison - Alpha Spread

S
SCU
vs
S
S&P/ASX 300

Over the past 12 months, SCU has underperformed S&P/ASX 300, delivering a return of 0% compared to the S&P/ASX 300's +9% growth.

Stocks Performance
SCU vs S&P/ASX 300

Loading
SCU
S&P/ASX 300
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
SCU vs S&P/ASX 300

Loading
SCU
S&P/ASX 300
Difference
www.alphaspread.com

Performance By Year
SCU vs S&P/ASX 300

Loading
SCU
S&P/ASX 300
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Stemcell United Ltd vs Peers

No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Stemcell United Ltd
Glance View

Market Cap
2.3m AUD
Industry
Biotechnology

Stemcell United Ltd. engages on using stem cell technology to grow and extract plant essence. The company is headquartered in Sydney, New South Wales. The company went IPO on 2000-06-13. The firm offers a range of products include Caulerpa lentillifera, Dendrobium officinale, Daemonorops draco Blume, and Cannabis sativa. The firm's geographical segments include Australia, Singapore, Greater China, and Malaysia.

SCU Intrinsic Value
Not Available
S
Back to Top